| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Aguilar, Ariadna |
| dc.contributor.author | Codina, Claudia |
| dc.contributor.author | Marín García, Antonio |
| dc.contributor.author | Alcalá-González, Luis Gerardo |
| dc.contributor.author | Guillen-Del-Castillo, Alfredo |
| dc.contributor.author | Barber Caselles, Claudia |
| dc.contributor.author | Malagelada, Carolina |
| dc.contributor.author | Simeón-Aznar , Carmen Pilar |
| dc.date.accessioned | 2025-01-21T09:26:47Z |
| dc.date.available | 2025-01-21T09:26:47Z |
| dc.date.issued | 2024-11-27 |
| dc.identifier.citation | Alcala-Gonzalez LG, Guillen-Del-Castillo A, Aguilar A, Barber C, Codina C, Marin Garcia A, et al. Impact of gastrointestinal symptoms and psychological distress on quality of life in systemic sclerosis: a cross-sectional study. BMJ Open. 2024 Nov;14:e089725. |
| dc.identifier.issn | 2044-6055 |
| dc.identifier.uri | https://hdl.handle.net/11351/12451 |
| dc.description | Motility disorders; Psychological Stress; Quality of Life |
| dc.description.abstract | Background Systemic sclerosis (SSc) is a chronic autoimmune disease characterised by microvascular damage and fibrosis. Mortality in patients with SSc has significantly decreased. Consequently, patients with SSc have longer life expectancy, and health-related quality of life (HrQoL) has become more relevant in the comprehensive management of the disease.
Objective To evaluate the impact between gastrointestinal (GI) symptom burden and psychological well-being on HrQoL in patients with SSc.
Design Nested cross-sectional study conducted between January and July 2022.
Participants A single-centre cohort of 166 patients with SSc, including 103 (55%) with limited cutaneous SSc, 43 (24%) with diffuse SSc and 37 (21%) with sine-sclerosis SSc.
Main measures GI symptom burden was assessed using the University of California Los Angeles Scleroderma Clinical Trial Consortium gastrointestinal tract 2.0 (UCLA SCTC GIT 2.0) questionnaire, psychological well-being was measured with the Hospital Anxiety and Depression Scale (HADS), and HrQoL was evaluated using the Short Form 36 (SF-36) questionnaire. Demographic, clinical and immunological data were collected from a prospectively maintained database.
Key results Patients with moderate to severe GI symptoms (UCLA SCTC GIT 2.0 score >0.5, n=95, 57%) reported decreased HrQoL in all subdomains except vitality by SF-36, and higher anxiety and depression scores by HADS (all p<0.05). The severity of GI symptom burden and depression were independently associated with a decline in the physical component of QoL (β=−0.273 and β=−0.411, respectively, p<0.01 for both). Only the severity of depression and anxiety (β=−0.482 and β=−0.213, respectively, p<0.05), but not GI symptom burden, were independently associated with a decline in the mental component of QoL.
Conclusions Our data suggest that in patients with SSc, GI and psychological burden negatively influence quality of life independently, highlighting the need for a holistic approach to patient’s care. |
| dc.language.iso | eng |
| dc.publisher | BMJ |
| dc.relation.ispartofseries | BMJ Open;14 |
| dc.rights | Attribution-NonCommercial 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
| dc.source | Scientia |
| dc.subject | Pacients - Satisfacció |
| dc.subject | Estrès |
| dc.subject | Esclerosi sistemàtica progressiva |
| dc.subject | Aparell digestiu - Malalties |
| dc.subject.mesh | Stress, Psychological |
| dc.subject.mesh | Scleroderma, Systemic |
| dc.subject.mesh | Gastrointestinal Diseases |
| dc.subject.mesh | Quality of Life |
| dc.title | Impact of gastrointestinal symptoms and psychological distress on quality of life in systemic sclerosis: a cross-sectional study |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1136/bmjopen-2024-089725 |
| dc.subject.decs | estrés psicológico |
| dc.subject.decs | esclerodermia sistémica |
| dc.subject.decs | enfermedades gastrointestinales |
| dc.subject.decs | calidad de vida |
| dc.relation.publishversion | https://doi.org/10.1136/bmjopen-2024-089725 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Gerardo Alcala-Gonzalez L] Servei d’Aparell Digestiu, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Guillen-Del-Castillo A, Codina C] Servei de Medicina Interna, Unitat d’Inflamació i Autoimmunitat, Àrea de Malalties Autoimmunes Sistèmiques, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Aguilar A, Barber C] Servei d’Aparell Digestiu, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain. [Marin Garcia A] Servei d’Aparell Digestiu, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Malagelada C] Servei d’Aparell Digestiu, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Simeon-Aznar CP] Unitat d’Inflamació i Autoimmunitat, Àrea de Malalties Autoimmunes Sistèmiques, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
| dc.identifier.pmid | 39609018 |
| dc.identifier.wos | 001366264400001 |
| dc.relation.projectid | info:eu-repo/grantAgreement/ES/PEICTI2021-2023/PI22%2F01804 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |